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Abstract

Introduction

A novel in vitro model based on a solution mainly
composed of sodium, calcium, chloride and phosphate
ions, was developed to study the calcification of biomaterials at near physiological conditions. This model,
due to its ability to quickly calcify the tested materials,
is called Accelerated Calcification Solution (ACS). Polyactive™ 30170, Polyactive™ 70/30 and its composites
with nano-apatite were used as testing materials because
of their known calcification behaviour. The results
showed that Polyactive™ 70/30 and its composites could
calcify in ACS in a relatively short period, while the
polymer without filler failed to induce calcium phosphate
precipitation in more conventional Simulated Body Fluid
(1.5 SBF) in 9 days in this study. Polyactive™ 30170 did
not calcify in ACS and 1.5 SBF. As these results agreed
well with the known in vitro and in vivo calcification
behaviour of Polyactive™, we conclude that the ACS
solution is a suitable model to study the calcification
behaviour of biomaterials. The Ca-P mineral layer induced from ACS on Polyactive™ 70/30 and its composites was composed of octacalcium phosphate (OCP) and
calcium hydroxyapatite. It is likely that the OCP first
nucleated and grew on Polyactive™ 70/30 and its
composites, then gradually transformed to calcium
hydroxyapatite via hydrolysis. Also, the results showed
that nano-apatite has the ability to promote calcification
because nano-apatite/Polyactive™ 70/30 composites
could quickly calcify in ACS as well as in 1.5 SBF.

Calcification or formation of a calcium phosphate
phase in biomaterials is of great importance in biomedical science. Studies have demonstrated that calcification plays an important role in the bonding process
of bone prosthetic materials such as Polyactive™ (a
block copolymer of polyethylene glycol and poly (butylene terephthalate)) [2, 46, 47], hydroxyapatite [12, 13,
31, 48], Bioglass [26], glass ceramics [27, 28], and
silica gel [33, 34]. On the other hand, calcification is not
desirable in other applications ofbiomaterials, such as in
bioprosthetic heart valves (bovine pericardium and
porcine aortic valves) [18, 38], polyurethane heart
valves and blood pump blades [8, 49]. In vivo
calcification is a complicated biological process which
involves many factors like calcium binding proteins, and
cellular response of the host to the implants [42], and
there is no doubt that intrinsic factors of the material
play an important role in the process of calcification.
Examples of intrinsic factors are calcium ion complexing
ability of the material [45, 46], the dissolution rate of
calcium phosphate from the implanted material [9-13,
31, 48], the hydroxyl groups formed on the surface of
the material [33, 34] and the negative charges due to
pre-treatment [3 8].
Methods to promote or to prevent the calcification
process largely depend on the understanding of the
mechanism of the calcification process. Also, in
developing new materials for which the calcification is
of great significance, it is important to know how to
control the calcification process by engineering the
structure or the surface of the material. A simple and
rapid in vitro method is needed to examine the calcification properties of the material before cost and time
consuming animal experiments are performed. Several
in vitro tests have been developed such as the use of
Simulated Body Fluid (SBF) [27] for studying the ability
of the material to induce calcium apatite formation [3336] and several other in vitro models for studying
bioprosthetic heart valves and implantable polyurethane
[23, 24, 50]. In practice, we found that those models are
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Table 1. Ionic concentrations of SBF, 1.5 SBF and ACS
Concentration (mM)

Na+

K+

Ca2 +

Mg2+

HC03-

c1-

HPOl

SOl

SBF

142

5

2.5

1.5

27

103

1

0.5

l.5SBF

213

7.5

3.8

2.3

6.3

223

1.5

0.75

ACS

136.8

4.64

3.87

-

-

144.5

2.32

-

Figure 2 (on facing page). SEM micrographs showing
the calcification developed on the materials. (a) The
incomplete coverage of Poly-active™ 70/30 by the
mineral layer after a 3 day immersion in ACS. (b) The
complete coverage of 10% nanoapatite-polymer composites by fluorescent mineral crystals after a 3 day
immersion in ACS. (c) The cross section of 10% nanoapatite composites showing calcification developed from
the top (right) of the material towards the bottom (left)
within the matrix. (d) Crystals on top of Polyactive™
70/30 after 6 days immersion in ACS. (e) Very dense
crystal plates on 50% nanoapatite-polymer composites
after a 6 day immersion in ACS. (t) Morphological
changes of the mineral layer. The bottom part of the
mineral(*) is dense while the crystal plates (arrow) still
exist on top of the dense mineral layer. This suggests
that the crystal plates gradually transformed to a dense
mineral layer, possibly accompanied by phase structure
transformation.

Ca

p

•

10

Energy (KeVI

Figure 1. The EDX analysis results showed that the
precipitation on the material was mainly composed of
calcium and phosphorus.
not sensitive enough or take a long time to reveal
differences between the ability of materials to induce
calcification, or are unstable as a solution at room
temperature. In this study, a new in vitro model using
an "Accelerated Calcification Solution (ACS)" was
developed. A series of materials with differing rates of
calcification was used to evaluate the effectiveness of
ACS.
Polyactive™ (from HC Implants, Leiden, The
Netherlands), a block copolymer from polyethylene
glycol and poly(butylene terephthalate), was chosen as
test material because its ability to calcify has been well
characterized [2, 39, 40, 46, 47]. By changing the
weight ratio ofPEG/PBT, a series of copolymers with

different rates of calcification can be obtained. In this
study, we chose Polyactive™ 30170 (which will not
calcify in vivo), Polyactive™ 70/30 (which can be
calcified in vivo and has bone-bonding ability) and a
series of Polyactive™ 70/30 apatite composites with
10%, 25%, and 50% weight percent of a nano-apatite
mineral powder.

Materials and Methods
Accelerated Calcification Solution (ACS)
ACS, which has a [Ca]/[P] ratio of 1.67, was prepared by dissolving analytical grade NaCl, CaCl2 and
K 2HP04 to the following ion concentrations: [Na+] =
42
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136.8 mM, [Cl"] = 144.5 mM, [K+] = 4.64 mM,
[Ca2 +] = 3.87 mM, and [HPO/] = 2.32 mM. The
solution was buffered with 50 mM Tris buffer at pH 7.4
at room temperature.
1.5 SBF, which has a ionic concentration of 1.5
times that of normal SBF, was also used and compared
with ACS. Table 1 gives the ionic concentrations of
SBF, 1.5 SBF and ACS.

Materials for ACS testing
Polyactive™ 30/70 and 70/30 (the figures represent
the PEG/PBT ratio) were obtained from HC Implants,
Leiden, The Netherlands. The molecular weight of PEG
segments is 1000 Dalton. Nano-sized hydroxyapatite
(nano-apatite) was synthesized by a hydrothermal
process described elsewhere [37]. Composites with
10%, 25%, 50% weight percen-tage nano-apatite were
made. Nano-apatite was added to a Polyactive™ 70/30
chloroform solution. After mixing by vigorously stirring,
the mixture was precipitated in a large amount of ether.
After drying, the precipitates were used for hot press
moulding at 20 ton of pressure and 195°C. Polyactive™
30170 and 70/30 granulates were directly used for hot
press moulding. The pressed plates were 2 mm thick.
The samples with a size of 10 x 10 x 2 mm for ACS
immersion testing were cut from the hot press plates.

Figure 3. SEM micrograph showing the segregated
globular mineral precipitated on Polyactive™ 30170

ACS and l.SSBF immersion experiment
Each sample was put into either 30 ml of ACS or
30 m1 1.5 SBF in a polystyrene disposable beaker,
sealed and put in a water bath shaker at 37°C. At day 3,
all the medium was exchanged at room temperature. At
3 and 6 days, the samples were taken out. After careful
rinsing in distilled water and subsequent drying, samples
were carbon coated for scanning electron microscopy
(SEM) (Philips 525; Philips Electron Optics, Eindhoven,
The Netherlands) and energy-dispersive X-ray analysis
(EDX) (Voyager; NORAN, Middleton, WI) analysis. A
small amount of precipitate was scraped off from the top
of the samples from stored in the ACS solution for infrared (Perkin Elmer 783, KBr tablets; Perkin Elmer,
analysis and powder X-ray diffraction
Norwalk,
analysis (XRD, Philips PW 1050, CuKa, 40 kV /35
rnA).
A stability test for ACS and 1.5 SBF was also
carried out under the same conditions without the
presence of samples in the solution. All immersion tests
were performed in triplicate.

Figure 4. SEM micrograph showing the induced calcium
phosphate layer on 10% nanoapatite/Polyactive™ 70/30
composites after a 3 day immersion in 1. 5 SBF.

en

fairly stable at 37°C. On day 3, all the samples were
covered by a layer of mineral except for Polyactive™
30170. This layer was composed of calcium and phosphate as confirmed by EDX (Fig. 1), and crystal plates
were found to have grown from the surface of the tested
materials (Fig. 2). For different materials, the coverage
of the mineral was different: Polyactive™ 70/30 was
incompletely covered by the calcium phosphate crystals
(Fig. 2a, 2d). Composites with nano-apatite filler were
all completely covered by the crystal plates (Fig. 2b,
2e). The thickness of covered mineral layer was proportionate to the filler content. At day 6, except for
Polyactive™ 30170, all the materials were completely
covered by a thick calcium phosphate layer. On some

Results
SEM and EDX results
ACS immersion. The stability test showed that the
ACS solution was quite clear without precipitation
during the test period, indicating that the solution is
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Figure 5. The infra-red spectra of minerals induced from ACS on different materials: (1) on Polyactive™ 70/30, (2)
On 50% nanoapatite composites. Note the HP04 absorption bands in the spectra.
occasions, some isolated larger globular calcium
phosphate mineral spots (confirmed by EDX) were
found on top of Polyactive™ 30170 and on the walls of
the polystyrene disposable beaker with sizes exceeding
100 mm (Fig. 3).
Calcification of the bulk material was also observed.
This calcification had developed from the top of the
material towards the bottom of the sample as seen from
the cross section of the material (Fig. 2c).
1.5 SBF immersion. The stability test for 1.5 SBF
showed that the solution is also a stable solution during
the testing period. Polyactive™ 70/30 and Polyactive™
30170 both failed to induce calcium phosphate precipitation after 9 days. However, the composites of nanoapatite/Polyactive™ 70/30 had induced calcium phosphate precipitation when immersed for 3 days (Fig. 4)

30, 43].
The XRD Spectra and the computer data analysis
suggested that the calcium phosphate layer formed on
the materials has both the octacalcium phosphate
structure and calcium hydroxyapatite structure (Fig. 6).

Discussion
An ideal in vitro model to evaluate the calcification
ability of biomaterials should be able to produce a
mineral layer on the surface of the material within a
short period of time, and the results should be predictive
for the in vivo results. Polyactive™ 70/30, as has been
demonstrated, can be calcified both in vitro and in vivo
while Polyactive™ 30170 does not have the ability to
become calcified [2, 46, 47]. In the present study, the
results of the ACS model agreed very well with these in
vivo tests, because Polyactive™ 70/30 became calcified,
in contrast to Polyactive™ 30170. On the other hand,
1.5 SBF, although capable of inducing a Ca-P layer on
nano-apatite composites, failed to produce a Ca/P layer
on Polyactive™ 70/30 not even after 9 days immersion.
In these respects, ACS is a preferable solution for in
vitro testing, because of its ability to produce Ca-P layer
on the biomaterials within short periods, and the results
correlate very well with in vivo experimental results.

Infra-red and XRD spectra of the Ca/P mineral layer
induced in ACS
TheIR spectra of the mineral layer were basically
similar regardless of the composition of the materials
used in this study (Fig. 5). The broad bands at 38003000 and 1615 cm- 1 are H20 absorptions. The peaks at
1080, 1030, 964 cm- 1 are absorptions from P04-3 groups.
HP04-2 bands can be seen at 1280, 1200, 923, 868 and
530 cm- 1, and those are typical for octacalcium
phosphate (OCP, CagH2(P03) 6 .5H20) [3, 4, 17, 19, 20,
45
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Figure 6. The XRD spectrum of the minerals induced from ACS after a 6 day immersion (1). (2) is an apatite
spectrum. Note the OCP peaks (0) and the apatite peaks (A) in spectrum 1.
The ACS in this study is a highly supersaturated
calcium and phosphate solution similar to the solution
used by Golomb et al. [24]. The [Ca2 +] [HPO/] = 9
mM 2 , and [Ca]/[P] was kept at 1.67, which is the same
ratio as in hydroxyapatite. The existence of relatively
large amounts of Na + and c1·, from NaCl, actually
decreases the ion activity product (lAP) of Ca2+ and
HPOl, resulting in lAP < [Ca2 +][HPO/] = 9 mM2 •
Therefore the ACS solution is quite stable as compared
to the solution used by Golomb and Wagner [24].
The first step in calcification, as in any crystal
precipitation, is nucleation from the supersaturated
solution. However, supersaturation alone does not mean
that nucleation will occur. In order for nucleation to
occur, a certain amount of energy is needed for the
system to overcome the activation energy barrier. The
value of the activation energy is the critical factor in

determining the rate of nucleation in a supersaturated
system. Generally speaking, there are two ways to lower
the activation energy: (1) increasing the degree of
supersaturation, or (2) decreasing, at a given supersaturation, the interfacial energy [16]; the latter can be
achieved by introducing a solid, where the solid/ion
cluster interfacial energy can be lower than the
surface/solution and ion cluster/solution. interface
energies. Under those conditions nucleation can occur at
the solid surface, followed by crystal growth.
It has been demonstrated that Polyactive™70/30 has
the ability to absorb Ca2 + from calcium containing media
probably through a Ca2 + complexing mechanism of PEG
segments [2, 45, 46]. Therefore, when Polyactive™
70/30 samples are put in ACS solution, Ca2 + and HPO/"
ions will diffuse into the polymer matrix. Because of the
calcium ion complexing ability of the PEG segment, the
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Ca2 + concentration within the polymer matrix and near
the surface can reach high values locally. Therefore, the
activation energy of nucleation for calcium phosphate is
decreased both by the introduction of the Polyactive™
surface and the increased degree of supersaturation.
Once the nucleation of the mineral occurs at the surface
of polymer, it will be easily followed by the mineral
crystal growth on these surface nucleation sites.
Calcification can also develop towards the centre of the
sample due to the relatively high concentrations of Ca2+
and HPOl in the permeable polymer matrix. On the
other hand, the availability of space for crystal growth
will favour calcium phosphate precipitation on the
surface of the already formed Ca-P layer.
According to the discussion above, in order to
decrease the activation energy for nucleation, the
supersaturation of the solution should be as high as
possible, but should not exceed the critical supersaturation above which homogenous nucleation will
occur and which renders the solution unstable. Use of
both IR and XRD is a reliable way to determine the
structure of Ca-P mineral [30, 32]. The Ca-P layer
induced from ACS is mainly composed of OCP and
calcium hydroxyapatite according to IR and XRD
Spectra. The IR absorption bands for OCP and apatite
have been extensively studied and reviewed, and are
readily available [3, 4, 17, 19, 20, 30, 43]. The IR
spectrum of the mineral obtained in this experiment is
quite similar to that of OCP, including some typical
absorption bands for OCP: P-OH bending modes at 1280
em·• and 1200 em·•; P-OH stretching mode of HP04
groups at 920 em·• and 869 em·•; and HO-P03 bending
mode in HP04 at 530 em·•. However, IR spectra can not
reveal whether the mineral is only OCP or a mixture of
OCP and hydroxyapatite. XRD results clearly showed
the mineral had the structure of OCP and hydroxyapatite
(Fig. 6). SEM observation showed that the original
plate-like crystals (typical OCP crystal morphology)
were gradually transformed into a dense crystal layer
with the plate-like crystal on top. Therefore we conclude
that the calcium phosphate layer was composed of OCP
and calcium hydroxyapatite. The calcium hydroxyapatite
was likely transformed from OCP. The transformation
of OCP to apatite is possible. The transformation
mechanisms have been extensively described by other
authors [6, 7, 15, 16, 29, 30].
It is not surprising to find that the Ca-P layer is
composed of OCP because OCP nucleates and grows
more easily than hydroxyapatite. OCP often occurs as a
transient intermediate in the precipitation of thermodymimically more stable hydroxyapatite and biological
apatite [17]. It is widely believed that OCP is the bone
mineral precursor [6, 7, 14, 17, 30] and the dentin
precursor [14] due the strong similarity beween their

structures. The close structural relationship between
OCP and hydroxyapatite has been used to explain the
incorporation (via hydrolysis) of impurities, particularly
CO;", Mgl+ and Na+. Therefore, this ACS solution
might also be useful for studying the transition process
of OCP to hydroxyapatite and biological apatite.
Nano-apatite was suggested to have better
osteoconductivity than sintered hydroxyapatite particles,
due to its similarity to bone mineral in morphology,
crystal structure, composition and crystallinity [37].
However, no direct evidence to prove this has been
provided. In the present and previous experiments, it has
been found that addition of nano-apatite to Polyactive™
indeed improves the ability of the polymer to calcify
both in SBF and ACS. The possible mechanisms of the
improvement are: (1) the nano-apatite dispersed in
Polyactive™ may act as a nucleation site for the OCPlike phase, (2) incorporation of nano-apatite to the
polymer may increase the Ca2+ and HPO/"
concentrations within the polymer. Both mechanisms
will decrease the interfacial energy of the solid surface.
Thus, a calcium phosphate mineral layer can be formed
on the surface of polymer within a shorter period of
time. It has also been found that addition of calcium
phosphate to Polyactive™ promoted calcification both in
vitro and in vivo [21, 22].
Our experimental results suggest that the
supersaturation of ACS is beneficial for the speed of
testing the calcification ability of materials. 1.5 SBF
failed to induce a layer of mineral on Polyactive™ 70/30
within 9 days immersion period. Two factors may contribute to this. First, lAP, the product of [Ca2+][HPOl],
in 1.5 SBF is less than lAP in ACS, or the interfacial
energy of Polyactive™ 70/30 is higher in 1.5 SBF than
in ACS. The second factor is the presence of Mg2 + and
other ions in SBF. It is known that Mgl+ can inhibit the
nucleation of apatite, as has been shown for the
induction period of apatite nucleation on silica gel [5,
35]. Hence, as compared to ACS, the induction time of
the nucleation in 1.5 SBF may be quite long, and
therefore no Ca-P precipitation occurs within a short
period of time, unless the material has a very strong
ability to calcify.
In Polyactive™ 30/70 materials, some isolated,
large Ca-P globular deposits could be observed on the
surface (Fig. 3). Those globules have a very different
morphology from the Ca-P layer on Polyactive™ 70/30
(Fig. 2), and do not necessarily indicate an ability of the
material to calcify. In our experience, a confluent
mineral layer formation is the indication of such ability.
SBF solution has been extensively used due to the
fact that its ion concentrations are similar to that of body
fluid, and it can produce carbonated apatite on biomaterials [27, 33-36]. Although the ion concentrations
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in ACS solution are different from those in body fluid,
and ACS does not give rise to carbonated apatite
formation, it does show the nucleation ability of calcium
phosphate on the materials as discussed above. Therefore, ACS is a suitable model for the study of the ability
of biomaterials to induce Ca-P nucleation and growth,
whereas SBF would be a more suitable solution to
produce carbonated apatite coatings on biomaterial
surfaces and indeed has been successfully used for such
purposes [1, 25, 44].
From our results, we conclude that ACS is a
suitable model solution for the examination of the
calcification ability of materials in vitro. Although SBF
has proven to be capable of inducing precipitation of a
carbonated calcium phosphate layer on certain materials,
even concentrated solutions failed to induce precipitation
on Polyactive™ 70/30 after 9 days immersion in our
experiment. Since this polymer has been shown to
become rapidly calcified in vivo, SBF does not seem to
be a proper model for fast screening of the differences
in the calcification ability of materials. ACS, however,
forms a thick layer of calcium phosphate on the 70/30
polymer and its composites. Therefore, ACS may be
used for more rapid screening of materials regarding
their ability to calcify in vivo.

[5] Blumenthal NC (1989) Mechanisms of inhibition
of calcification. Clin Orthopaed Rel Res 247: 279-289.
[6] Brown WE (1962) Crystal structure of octacalcium phosphate. Nature (London) 196: 1048-1055.
[7] Brown WE, Eidelman N, Tomazic B (1987)
Octacalcium phosphate as a precursor in biomineral
formation. Adv Dent Res 1: 306-313.
[8] Coleman D (1981) Mineralizationofblood pump
bladders. Trans Am Soc Artif Intern Organs 27: 708713.
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Crystal dissolution of biological and ceramic apatites.
Calcif Tissue Int 45: 95-103.
[11] Daculsi G, Passuti N, Martin S, Deudon C,
Legeros RZ, Raber S (1990) Macroporous calcium
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Scanning and transmission electron microscopy, and
electron probe analysis of the interface between implants
and host bone. Osseo-oalescence versus osseointegration. Scanning Microsc 4: 309-314.
[13] Daculsi G, LeGeros RZ, Heughebaert M ,
Barbieux I (1990) Formation of carbonate-apatite
crystals after implantation of calcium phosphate
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[16] Eanes ED (1992) Dynamics of calcium phosphate precipitation. In: Calcification in Biological
Systems. Bonucci E (ed). CRC Press, Boca Raton, FL,
pp 1-17.
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calcium orthophosphate. In: Structure and Chemistry of
the Apatites and Other Calcium Orthophosphates.
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[18] Ferrens VJ, Boyce SW, Billingham ME, Jones
M, Ishihara T, Roberts WC (1980) Calcific deposits in
porcine bioprostheses: structure and pathogenesis. Am
J Cardiol 46: 721-734.
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Infra-red spectra of hydroxyapatite, octacalcium

Conclusion
A novel and simple in vitro model to examine the
calcification of biomaterials has been developed in the
present study. In combination with the known calcification behaviour of Polyactive™, this model solution
has proved to be fast and effective for a comparison of
the calcification rate of biomaterials. This study also
showed that by incorporating nano-apatite into Polyactive™, the calcification rate of the resulting materials
can be significantly enhanced.
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supersaturated Ca-P solutions might lead to misleading
results. Therefore, in our experiment both negative
controls (Polyactive™ 30170, polystyrene beaker itself)
and positive control samples (Polyactive™ 70/30) were
used. Although some isolated Ca-P spots were also
found in negative control samples as stated in the
manuscript, they were morphologically quite different
from the Ca-P mineral layer on PolyactiVO™ 70/30 and
its composites. Therefore, we stated that "those globules
have a very different morphology from the Ca-P layer
on Polyactive™ 70/30 (Fig. 2), and do not necessarily
indicate an ability of the material to calcify. In our
experience, a confluent mineral layer formation is the
indication of such ability. Thus we feel that our results
are unlikely to be misleading.
The ACS solution has been used in our laboratory
for a long time and proved to be successful not only in
the case of Polyactive™, but also in the case of plasma
sprayed calcium phosphate coatings and fluoride calcium
phosphate coating, titanium and its alloy [53], modified
bamboo [52], etc.
G. Daculsi: The authors should determine the ionic
concentrations (Na, Ca, Cl, P, K) in solution after
incubation.
Authors: It would offer some additional advantages if
the ionic concentrations of Na, Ca, P, Cl, K were
determined. Since we have used EDX to identify all the
precipitation which was visible under SEM, and the
precipitation was further identified by IR and XRD, we
feel that it is not absolutely necessary to further
determine the ionic concentrations.

Discussion with Reviewers
K.M. Kim: As opposed to the authors' claim of the
"near physiological conditions," the degree of
supersaturation in ACS is excessive. The [Ca]x[PJ
product in ACS is several times greater than that of
human body fluid. The results obtained from such a high
degree of supersaturation are likely to be misleading.
Any in vitro study should simulate in vivo phenomena as
closely as possible. In a simple aqueous solution,
spontaneous calcification takes place at much lower
concentrations of Ca and Pi (e.g., Boskey and Posner
[51]). It is not surprising that non-apatite is the
predominant deposit formed in vivo. The authors ignore
calcific deposits (?) on the surface of Polyactive™ 30170
(Fig. 2c).
Authors: In our opinion the ACS solution is in a near
physiological condition because of the pH (7-7.4), ionic
strength and temperature (37°C) of the solution.
Although the [Ca][PJ product is several times higher
than that of normal circulated human body fluid, it is
very likely that in a local area where bone is in a
process of healing, 'the [Ca][Pi] product is also several
times higher than that of normal body fluid. We do
agree with the reviewer that working with such highly

G. Daculsi: How is it possible with the high content of
Cl and Na, compared to Ca and P, that you do not
observe these ions by EDX on "precipitation"?
Authors: Although the Na+ and Cl· concentrations in
ACS are high, the concentrations are just as high as that
in a normal saline (0.8 % NaCl). The reason why Na+
and Cl· were not observed in the Ca-P precipitates is still
unknoWn. We speculate that one of the reasons is
probably the high crystallinity of the Ca-P precipitation.
G. Daculsi: In SBF the precipitation is a carbonated
apatite similar to that obtained in vivo or in cellular
culture. In your case you see OCP. You can not compare and consider that ACS is better than SBF for
screening. If precipitation is not carbonated apatite, cell
adhesion (osteoblasts, osteoclasts) and phenotypic
expression cannot be similar.
Authors: Based on our experiment, we stated that ACS
is a suitable model to study the calcification of
biomaterials. One obvious reason is that Polyactive™
70/30, which can be calcified both in vivo and in vitro,
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can not be calcified in SBF. More precisely, ACS is a
model to study the ability ofbiomaterials to induce Ca-P
nucleation and precipitation, and this ability is generally
believed to have a close correlation to the in vivo
calcification behaviour of biomaterials. It is not our
intention to say that the calcification layer induced from
ACS is better than that from SBF in view of the
biological properties.
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